FREDERICK, Md. (PRWEB)
September 26, 2022

Register now to attend the FREE one-day Federal Government Contracting Conference, reserved exclusively for representatives of small and small-disadvantaged business enterprises. Instructors will walk small groups of attendees through the highly regulated and often confusing federal government contracting process. Attendees will be assigned to one of three groups of 7-8 students and one instructor, affording each attendee ample opportunity to learn, network with colleagues and ask questions.

The one-day training session is free and is being offered on a first come, first serve basis. There are a limited number of openings, so please reserve your space today!

To reserve your seat, send your name, title, company, email address and phone number to: dennis.chaloux@nih.gov. Attendees will receive an email reservation confirmation along with additional instructions.

Share article on social media or email:

In its first year under the ownership of HMP Global, the Senior Care Marketing & Sales Summit (SMASH) has sold out its 2022 meeting, slated for October 24-26 in Las Vegas.

MALVERN, Pa. (PRWEB)
September 26, 2022

In its first year under the ownership of HMP Global, the Senior Care Marketing & Sales Summit (SMASH) has sold out its 2022 meeting, slated for October 24-26 in Las Vegas.

SMASH is the premier meeting for C-Suite sales and marketing executives within senior housing and post-acute care organizations looking to master strategies that capture market share and win customers. HMP Global, the world’s largest healthcare event and education company, acquired the event in February, as part of its expanding senior care portfolio that includes the Senior Living Executive Conference and the Annals of Long-Term Care medical journal.

The SMASH event this year features more than 50 educational sessions over three days, along four robust learning tracks: digital marketing; marketing strategy and management; post-acute care; and sales strategy and management.

“Today’s senior housing customer is not the customer of the past,” said Bailey Beeken, SMASH organizer and managing director. “Eighty percent of sales happen before your team members speak or meet with a prospect. Now more than ever, marketing and sales must engage customers at a highly personalized level through a mix of traditional, digital, and social platforms. Whether you’re offering assisted living, memory care, life plan, or independent living community settings, SMASH offers the latest tactics and strategies to compete and win.”

To accommodate the growing need, she said, SMASH organizers are planning a larger event in 2023 that will build on this year’s program with critical training and professional development for senior care sales and marketing professionals. Next year’s event will be held October 16-18, 2023, at the JW Marriott Las Vegas Resort & Spa.

“There is inspiration and innovation at every turn at SMASH,” said conference board member Michelle Glass, corporate vice president, Senior Living and In-Home Services for Bethesda Senior Living. “Sessions are led by industry professionals with up-to-date, real-life information and strategies. This is a community of like-minded people who are passionate about those we serve.”

SMASH offers the latest marketing and sales strategies, delivered in action-oriented sessions with helpful take-aways, including lead generation and conversion strategies, data measurement and management, media strategy, marketing automation, small team strategies, and the latest updates in grassroots and traditional marketing. It also features updates on executive-level sales management, including talent acquisition and retention, process management, and working with cross-functional teams.

For more information, visit seniorcaremarketingsummit.com.

ABOUT HMP GLOBAL 

HMP Global is the force behind Healthcare Made Practical—and is an omnichannel leader in healthcare content, events, and education, with a mission to improve patient care. The company produces accredited medical education events – in person and online via its proprietary VRTX virtual platform – and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include the HMP Global Learning Network, healthcare’s most comprehensive source for news and information; Psych Congress, the largest independent mental health meeting in the U.S.; the Evolution of Psychotherapy, the world’s largest independent educational event for mental health professionals; the Leipzig Interventional Course (LINC), the leading, global gathering for interdisciplinary cardiovascular specialists; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

Share article on social media or email:

MoMe™ ARC

We were the first FDA-approved deep learning software-as-a-service remote cardiac monitoring platform for the home that replicates in-hospital style monitoring to capture and stream beat-to-beat full disclosure cardiac data for 24/7 on-demand review while allowing for global billing.

WALTHAM, Mass. (PRWEB)
September 26, 2022

The Virtual Telemetry Company, InfoBionic, is introducing the cloud-based MoMe™ ARC (Advanced Remote Cardiology) Platform capable of capturing real-time to near real-time cardiac monitoring data. There are no limits to the level of medical complexity. The MoMe™ ARC Platform is being designed as noninvasive and adaptable for low-acuity to high-acuity patients in both inpatient and outpatient settings.(2) MoMe™ ARC technology also is intended to support a range of compatible third-party RPM (remote patient monitoring) devices, such as blood pressure cuffs, oximeters, and scales.(4)

MoMe® cardiac devices can detect and assist clinicians with the diagnoses of up to 30 different arrhythmias.(1) When a patient presses a button on the device, the cardiologist receives the patient’s data on a cell phone, tablet, or PC and can immediately make a cardiac arrhythmia diagnosis.(3) Patients become more engaged in their health care, and waiting days to weeks for test results is no longer the norm.

The next generation MoMe devices and sensors are being designed to offer virtual, high-fidelity cardiac data using Bluetooth® technology, with the intention to allow for maximum comfort. The intended highly durable and water-resistant designs will allow for monitoring a patient’s cardiac activity no matter where they are, much like it already does today. We see a future where battery management becomes a thing of the past and know that integrated battery and wireless charging capabilities, will offer the most convenience and peace of mind.(4)

The future of the MoMe™ ARC platform is being designed for continuous monitoring from hospital to home with no data interruption. The plans include to offer configuration flexibility a modular lead set suite from 1 channel to 3 channels to best suit each patient’s individual needs. MoMe™ Solutions enables secure access for healthcare providers to interpret patient data with AI-assisted analysis, quality control, alerting, and reporting.(4)

InfoBionic CEO Stuart Long explains, “We were the first FDA-approved deep learning software-as-a-service remote cardiac monitoring platform for the home that replicates in-hospital style monitoring to capture and stream beat-to-beat full disclosure cardiac data for 24/7 on-demand review while allowing for global billing. We like to say that we see 100% of the heartbeats, 100% of the time. Our mobile cardiac monitoring system shortens the distance between physicians and their patients, giving them new levels of control and deeper insight to make more efficient and effective decisions and diagnoses—all while optimizing the patient experience and the practice’s workflows.”(3)

Long also notes that “as healthcare moves away from the traditional fee-for-service model, our unique Software as a Service (SaaS) solution positions the practice to better adapt to and compete in a value-based system.”(5)

The InfoBionic® mission statement is to enable the first virtual telemetry system for low- to high-acuity patients from hospital to home. InfoBionic helps improve patient outcomes and saves lives.

About InfoBionic®

InfoBionic’s digital technology has transformed the efficiency and economics of cardiac remote patient monitoring. The company’s MoMe™ARC platform has removed the

roadblocks hindering remote diagnosis and decision-making. The seasoned entrepreneurs on the Massachusetts-based team have had successful careers in healthcare, IT, medical devices, and mobile technology and bring specific expertise in remote monitoring and cardiology. More recently, working side by side with the healthcare and medical technology communities, including its competitors, InfoBionic has developed MoMe™ Now, the first virtual telemetry system for high-acuity patients in remote, virtual, or hospital-at-home care environments. Visit InfoBionic.com

Sources:

1) “InfoBionic to Introduce First Virtual Care Hospital Grade Telemetry Platform at Heart Rhythm Society Conference.” Cision PRWeb, 6 April 2022, web, prweb.com/releases/infobionic_to_introduce_first_virtual_care_hospital_grade_telemetry_platform_at_heart_rhythm_society_conference/prweb18599253.htm

2) “InfoBionic Introduces New Monitoring Technology as Part of Virtual Telemetry Platform.” InfoBionic, 27 April 2022, web, infobionic.com/infobionic-introduces-new-monitoring-technology-as-part-of- virtual-telemetry-platform/

3) Zehr, Leonard. “Stuart Long Outlines InfoBionic Remote Cardiac Arrhythmia Monitoring Benefits.” BioTuesdays, 27 April 2021, web, biotuesdays.com/2021/04/27/stuart-long-outlines-infobionic-remote-cardiac-arrhythmia-monitoring-benefits/

4) “The MoMe™ ARC Platform Remote Cardiac Monitoring at the Heart of Virtual Care.”

5) InfoBionic, 29 April 2022, web, infobionic.com/mome-arc-platform/

6) “InfoBionic: Digitally Transcending the Future of Virtual Healthcare.” InsightsCare, 23 June 2022, insightscare.com/infobionic-digitally-transcending-the-future-of-virtual-healthcare/

Share article on social media or email:

JT Thomas, FORCE3 team, Steven Goldsmith, FORCE3 CEO, Tyler Heineman, MLB Catcher&FORCE3 Owner/Brand Ambassador, Jason Klein, FORCE3 Founder&Executive Chairman, Sierra Alarid, FORCE3 team

There’s a need in the market for better protective gear that we are filling and continuing to fulfill, and the growing demand requires more resources, more research and development, more space, and more commitment.

STRATFORD, Conn. (PRWEB)
September 26, 2022

FORCE3 Pro Gear, a leader in the protective sports gear industry, launched an exciting new partnership with Susan G. Komen, while unveiling its state-of-the-art facility expansion. The two initiatives helped solidify the company’s leadership role in the industry and commitment to safeguarding good health.

“We are privileged to partner with Susan G. Komen and excited about the role we can play to help the ground-breaking organization save lives and end breast cancer,” said Steven Goldsmith, CEO and President at FORCE3 Pro Gear. “FORCE3 was founded on the principle of protecting people, whether through the manufacture of protective sports gear or by partnering with like-minded organizations such as Susan G. Komen.”

Representatives from the non-profit cancer organization attended the expansion unveiling festivities, offering their perspective on the newly forged partnership with FORCE3. “We are honored to partner with FORCE3 and appreciate its commitment to safety and high-quality protective gear for athletes. Our respective organizations are dedicated to improving outcomes and eliminating barriers so that everyone can benefit from advancements in research and technology, whether on the field or in health care,” said Nicole Marohn, State Executive Director for New England, at Susan G. Komen.

Support for Susan G. Komen kicked off at FORCE3’s facility expansion unveiling, with silent auctions and giveaways to raise funds. The new facility debut took place at FORCE3’s head office in Stratford, Connecticut on Jason Klein Way, named after the innovative company founder.

The facility expansion is a result of the significant growth FORCE3 is experiencing and a key component in the safety-first company’s future growth strategy. “The expansion, which includes a larger corporate office, more warehouse space, expanded product development and research and development lab facilities and a new retail storefront (open M-F, 9-5), is borne of necessity,” said Goldsmith “The company’s growth has been explosive because of the overwhelmingly positive response the baseball and softball industries have given its protective gear lineup. There’s a need in the market for better protective gear that we are filling and continuing to fulfill, and the growing demand requires more resources, more research and development, more space, and more commitment.”

FORCE3’s steadfast commitment to its industry, community and unrelenting innovation is receiving recognition and being celebrated by the State of Connecticut. “Congratulations to FORCE3 on its growth and grand opening of its headquarters in Stratford,” said Paul S. Lavoie, Chief Manufacturing Officer, State of Connecticut. “Connecticut is proud of our long history of innovation and FORCE3 is a great example of innovation borne from personal experience. We look to support FORCE3 as the company deepens its roots in Connecticut and continues to grow and innovate. Best wishes to Jason, Steven, and the entire team as they lead the protective athletic equipment industry.”

The facility expansion and newly forged partnership with Susan G. Komen are just a few of many firsts to come, according to Goldsmith. “It’s an exciting time for FORCE3. We’re working on several new initiatives that will help us protect even more people from serious injuries – there’s a lot more to come.”

About FORCE3 Pro Gear

FORCE3 Pro Gear conceives and manufactures the safest protective sports gear in the industry with the mission of ending concussions and other serious injuries. Owned and founded by a former umpire and MLB players, every aspect of FORCE3’s gear is scrutinized and built to withstand the rigor of the game. The company’s patented Shock Suspension System (S3) has revolutionized sports equipment safety, and FORCE3 is committed to the advancement of this and new technologies to keep players at all levels safe, offering Protection For Life.TM FORCE3 is an official catcher’s mask of the MLB Players, Inc. To learn more, visit http://www.FORCE3progear.com or @FORCE3progear on Facebook, Twitter or Instagram.

About Susan G. Komen®

Susan G. Komen® is the world’s leading non-profit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at http://www.komen.org/contact-us/follow-us/.

Share article on social media or email:

FBDD exhibits several advantages over high-throughput screening campaigns in terms of cost, chemical diversity, and broader sampling for potential follow-up compounds.

TORONTO (PRWEB)
September 26, 2022

Fragment Based Drug Discovery (FBDD) has become of increasing importance and interest in the past decade for hit finding and optimization. FBDD led to approved therapeutics and numerous drug candidates. It has empowered the industry to address targets that had previously been deemed “undruggable”.

FBDD uses the advantages of biophysical, biostructural and biochemical methods for the detection of low molecular weight molecules, so-called “fragments”, that bind to a target. FBDD exhibits several advantages over high-throughput screening campaigns in terms of cost, chemical diversity, and broader sampling for potential follow-up compounds.

Numerous case studies of covalent and non-covalent screening fragment strategies have led to successful applications in druggability assessment of proteins. In this talk, experts in the field of FBDD will present case studies and potential of a spectrum of cutting-edge strategies for a successful hit identification and optimization campaigns.

In addition, Dr. Nir London (Weizmann Institute of Science, Israel) will present how electrophilic fragment screening can accelerate the discovery of a new generation of covalent probes for challenging targets. Here he will describe application of this method for the discovery of the first in-vivo active chemical probe for the proline isomerase Pin1, as well as against the SARS-CoV-2 main protease.

Join this webinar to learn how fragment-based drug discovery solutions —such as DRIVE-SM — enable the identification, characterization, design and optimization of fragments into a preclinical drug candidate.

Join Dr. Thomas Schubert, Managing Director, 2bind; Dr. Serghei Glinca, Founder & CEO, CrystalsFirst; Dr. Nir London, President of the Med. Chem. Section of the Israel Chemical Society, Weizmann Institute; and Dr. Yann Lamotte, Chemistry Team Manager, Oncodesign, for the live webinar on Thursday, October 13, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Fragment-Based Drug Discovery — Hitting Targets Using the Right Chemistry and Expertise Alliances.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: